CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly licensed Geenius test is an immunochromatographic assay designed to confirm and differentiate individual antibodies to Human Immunodeficiency Virus Types 1 and 2. The assay will be replacing the HIV-1 Western blot and HIV-2 EIA assays which are performed on samples with a reactive result on a licensed HIV 1/2 screening test.
Read all about it on the Communication page by clicking this link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
The new online Learning Center with new content can still be found under the “Training” folder on ...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
This is the first update to the original CTS communication distributed on July 6th. As previously co...